Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Oncternal Therapeutics

Oncternal Therapeutics

Oncology antibody treatments

Overview Structured Data Issues Contributors Activity

Is a

Company attributes

Industry

0

Biomedical engineering

Biopharmaceutical

Location

0

B2X

0

CEO

James B. Breitmeyer

0

Pitchbook URL

pitchbook.com/profiles...160566-58

Legal Name

Oncternal Therapeutics, Inc.0

Number of Employees (Ranges)

11 – 50

Email Address

info@oncternal.com

investor.relations@oncternal.com0

Phone Number

+185843411130

Full Address

12230 El Camino Real, Suite 300 San Diego, CA 92130, USA0

CIK Number

Place of Incorporation

0

Investors

Mesa Verde Venture Partners

0

DUNS Number

0025707400

IRS Number

621,715,8070

Founded Date

2013

0

Fax Number

(858) 408 30100

Stock Symbol

ONCT0

Exchange

0

Board of Directors

William R. LaRue

0

0

0

Rosemary Mazanet

0

0

0

James B. Breitmeyer

0

Michael Carter (entrepreneur)

0

NAICS Code

325,4120

CAGE Code

38AG40

Patents Assigned (Count)

10

Country

Other attributes

Company Operating Status

Active

Contact Page URL

oncternal.com/contact

Previous Name

GTX INC/TN0

GTX INC /DE/0

Public/Private

Public0

SIC Code

2,8340

Ticker Symbol

ONCT0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Oncternal Therapeutics

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool